|
|
|
Volumn 13, Issue 1, 1998, Pages 24-35
|
|
What new antibiotics to offer in the outpatient setting
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
CEFACLOR;
CEFETAMET PIVOXIL;
CEFIXIME;
CEFPODOXIME PROXETIL;
CEFTIBUTEN;
CEPHALOSPORIN DERIVATIVE;
CLINIFLOXACIN;
LORACARBEF;
MACROLIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
UNCLASSIFIED DRUG;
ANTIBIOTIC THERAPY;
BACTERIAL PNEUMONIA;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG EXCRETION;
DRUG HALF LIFE;
GASTROINTESTINAL TOXICITY;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HEADACHE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
MINIMUM INHIBITORY CONCENTRATION;
ORAL DRUG ADMINISTRATION;
OUTPATIENT CARE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
REVIEW;
SKIN MANIFESTATION;
VERTIGO;
AMBULATORY CARE;
ANTI-BACTERIAL AGENTS;
CEPHALOSPORINS;
COMMUNITY-ACQUIRED INFECTIONS;
HUMANS;
MACROLIDES;
PNEUMONIA;
QUINOLONES;
|
|
EID: 0031917525
PISSN: 08820546
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (91)
|
